MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy
Translational Psychiatry · 10.09.2024 · 14 (1)
DOI: 10.1038/s41398-024-03075-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Psychiatry, online erschienen am 10.09.2024. Verfasst von Yao-Bo Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China. Hauptthemen laut MEDLINE: Alzheimer Disease, MicroRNAs, Amyloid beta-Peptides, tau Proteins. Die Arbeit wurde bisher 126-mal zitiert (Crossref) und nennt 256 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China (National Science Foundation of China).
Themen: Demenz
Abstract (Originalsprache)
This article delves into Alzheimer's disease (AD), a prevalent neurodegenerative condition primarily affecting the elderly. It is characterized by progressive memory and cognitive impairments, severely disrupting daily life. Recent research highlights the potential involvement of microRNAs in the pathogenesis of AD. MicroRNAs (MiRNAs), short non-coding RNAs comprising 20-24 nucleotides, significantly influence gene regulation by hindering translation or promoting degradation of target genes. This review explores the role of specific miRNAs in AD progression, focusing on their impact on β-amyloid (Aβ) peptide accumulation, intracellular aggregation of hyperphosphorylated tau proteins, mitochondrial dysfunction, neuroinflammation, oxidative stress, and the expression of the APOE4 gene. Our insights contribute to understanding AD's pathology, offering new avenues for identifying diagnostic markers and developing novel therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China.
- Institute of National Security, Minzu University of China, Beijing, China.
- Key Laboratory of Ethnomedicine of Ministry of Education, School of Pharmacy, Minzu University of China, Beijing, China.
- Chinese Academy of Sciences Key Laboratory of Brain Connectome and Manipulation, Shenzhen Key Laboratory of Translational Research for Brain Diseases, The Brain Cognition and Brain Disease Institute, Shenzhen Institute…
- Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen, China. yw.chen1@siat.ac.cn.
- Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China. yongcheng@muc.edu.cn.
ORCID-Profile: Yong Cheng
Förderung
- National Natural Science Foundation of China (National Science Foundation of China)
Zitieren
APA
Li, Y. B., Fu, Q., Guo, M., Du, Y., Chen, Y., & Cheng, Y. (2024). MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy. Translational Psychiatry, 14(1). https://doi.org/10.1038/s41398-024-03075-8
Vancouver
Li YB, Fu Q, Guo M, Du Y, Chen Y, Cheng Y. MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy. Translational Psychiatry. 2024;14(1). doi:10.1038/s41398-024-03075-8
BibTeX
@article{Li2024,
author = {Li, Yao-Bo and Fu, Qiang and Guo, Mei and Du, Yang and Chen, Yuewen and Cheng, Yong},
title = {MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy},
journal = {Translational Psychiatry},
year = {2024},
volume = {14},
number = {1},
doi = {10.1038/s41398-024-03075-8}
}
EUVIMED